There's finally something other than the Federal Reserve and "tapering" for traders to obsess over. At the beginning of last week, Alcoa (NYSE: AA ) unofficially kicked off second-quarter earnings season. If you're wondering how things are going thus far, here's a hint: The S&P 500 (SNPINDEX: ^GSPC ) proceeded to finish the week at a new all-time high of 1,680, up by 2.4%.
Now, it should be noted that Alcoa is no longer the economic bellwether it once was. As The Wall Street Journal pointed out, "It is not only a cliche that Alcoa 'sets the tone' for earnings season -- it is also no longer really true."
But while it isn't the bellwether of old, that's a far cry from saying that its results are irrelevant. It's for this reason that investors collectively exhaled when the aluminum giant reported better-than-expected earnings per share of $0.07 compared with a consensus estimate of $0.06 per share. On top of this, as my colleague Dan Carroll noted at the time, Alcoa still expects global aluminum demand to rise as much as 7% this year.
Best Gas Utility Stocks To Watch For 2015: Align Technology Inc.(ALGN)
Align Technology, Inc., a medical device company, designs, manufactures, and markets clear aligner systems or Invisalign systems, intra-oral scanners, and computer-aided design (CAD) and computer-aided manufacturing (CAM) restorative models used in dentistry, orthodontics, and dental records storage in North America and Internationally. The company?s clear aligner products include Invisalign Full for the treatment of malocclusions; Invisalign Express and Invisalign Lite solutions for less complex orthodontic cases; Invisalign Teen, which is primarily marketed to orthodontists for treating malocclusion in teenage patients; Invisalign Assist for use in anterior alignment and aesthetically-oriented cases; and Vivera retainers for invisalign and non-invisalign patients. It also offers ancillary products comprising cleaning material and adjusting tools used by dental professionals during the course of treatment. In addition, the company provides iTero scanners; iOC scanners; a nd iTero dual scanner, which includes both the iTero restorative software and the iOC orthodontic software, as well as services comprising iTero restorative and OrthoCAD services. Further, it offers CAD/CAM services, such as iTero Models and Dies; OrthoCAD iCast and OrthoCAD iRecord that provides a digital alternative to traditional stone cast models, which allows for simplified storage and digital record retrieval; and OrthoCAD iQ, a computer-guided system for optimal placement of traditional brackets and customized indirect bonding tray system. The company distributes its products primarily directly to orthodontists and general practitioner dentists, as well as restorative dentists, including prosthodontists, periodontists, and oral surgeons. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Align Technology (Nasdaq: ALGN ) , whose recent revenue and earnings are plotted below.
Top 10 Managed Healthcare Companies To Watch In Right Now: Balchem Corp (BCPC)
Balchem Corporation incorporated on Jan 30, 1967, is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in three segments: Specialty Products, Food, Pharma & Nutrition and Animal Nutrition & Health. The Company sells its products through its own sales force, independent distributors and sales agents. The Company operates five wholly owned domestic subsidiaries, such as BCP Ingredients, Inc., Aberco, Inc., Balchem BV, Balchem Trading BV and Balchem Italia Srl.
Food, Pharma & Nutrition
The Food, Pharma & Nutrition (FPN) segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, and packaging applications and shelf-life. Major product applications are baked goods, refrigerated and frozen dough systems, processed meats, seasoning blends, confections, and nutritional supplements. The Company also markets human grade choline nutrient products through this segment for wellness applications.
Specialty Products
The Company's Specialty Products segment operates in industry as ARC Specialty Products. Ethylene oxide, at the 100% level, is sold as a sterilant gas, primarily for use in the health care industry. It is used to sterilize a wide range of medical devices because of its versatility and effectiveness in treating hard or soft surfaces, composites, metals, tubing and different types of plastics. The Company's 100% ethylene oxide product is distributed in uniquely designed, recyclable, double-walled, stainless steel drums. Contract sterilizers, medical device manufacturers, and medical gas distributors are the Company's principal customers for this product. In addition, the Company also sells single use canisters with 100% ethylene oxide for uses in medical dev! ice sterilization.
The Company markets and sells propylene oxide as a fumigant to aids in the control of insects and microbiological spoilage and to reduce bacterial and mold contamination in shell and processed nut meats (except peanuts), processed spices, cacao beans, cocoa powder, raisins, figs and prunes. The Company distributes its propylene oxide product primarily in recyclable, single-walled, carbon steel cylinders The Company also sells propylene oxide to customers seeking smaller quantities and whose requirements include utilization in various chemical synthesis applications, to make paints more durable and for manufacturing specialty starches and textile coatings.
Animal Nutrition & Health
The Company's Animal Nutrition & Health (ANH) segment provides the animal nutrition and health markets with products derived from the Company's microencapsulation, chelation, and basic choline chloride technologies. Commercial sales of REASHURE Choline, a microencapsulated choline, NITROSHURETM, a microencapsulated urea, and NIASHURETM, the Company's microencapsulated niacin for dairy cows, boosts health and milk production in transition and lactating dairy cows, delivering nutrient supplements that survive the rumen and are biologically available, providing required nutritional levels. The Company's AMINOSHURE-L product, a rumen-protected lysine for use in dairy rations, gives nutritionists and dairy producers a precise and consistent source of rumen-protected lysine. The Company also markets chelated mineral supplements for uses in animal feed throughout the world. ANH also manufactures and supplies basic choline chloride, an essential nutrient for animal health, predominantly to the poultry and swine industries. The ANH segment also includes choline and certain derivatives manufactured and sold into various industrial applications, predominately as a component for hydraulic fracturing of shale natural gas wells, and methylamines which are a primary building block fo! r the man! ufacture of choline products and are also used in a wide range of industrial applications.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Balchem (NASDAQ: BCPC) shares shot up 15.27 percent to $60.08 after the company announced its plans to acquire SensoryEffects for $567 million.
Top 10 Managed Healthcare Companies To Watch In Right Now: Steamships Trading Company Ltd(PNG)
Steamships Trading Company Limited operates as a diverse trading conglomerate in Papua New Guinea. It involves in shipping, road transport, product manufacture, property, hotels, and information technology businesses. The company?s shipping business includes operation of a fleet of coastal vessels, and providing estuarine and river trades in the Gulf and Western Provinces; short and long term vessel charters, and cargo liner services using vessels ranging from 500DWT to 6000DWT; and stevedoring and shipping agency services. Its road transport business comprises general transport, fuel distribution, and long haul transport services; and customs clearance, handling equipment hire, integrated logistics, and specialist transportation services. Steamships Trading Company?s product manufacture business includes the production and distribution of food stuff comprising ice cream, vegetable oils, condiments, and seasonings; health and beauty goods; and spirits and premixed drinks , as well as involves in distributing imported wines and spirits. Its property business comprises residential, commercial, and industrial property development and leasing activities. The company?s hotel business engages in operating hotels. Its information technology business provides business-critical ICT consulting, solutions and services, IT outsourcing, business process outsourcing, Internet services, electronics and computer retail, and training and wide-ranging technical support. The company was founded in 1924 and is based in Port Moresby, Papua New Guinea. Steamships Trading Company Limited is a subsidiary of John Swire & Sons (PNG) Limited.
Advisors' Opinion:- [By Aaron Levitt]
And more could be in store. PAA has just agreed to swallow its former natural gas storage spinoff PAA Natural Gas Storage (PNG) in a $1.41 billion deal that will instantly be accretive to PAA shareholders. Meanwhile, Plains continues to build new capacity and crude-by-rail services in key refining markets like California.
- [By Jon C. Ogg]
Plains All American Pipeline L.P. (NYSE: PAA) was maintained as Outperform with a $64 price target (versus $51.44 current) after its announced acquisition of affiliated PAA Natural Gas Storage L.P. (NYSE: PNG) in an all-stock buyout.
Top 10 Managed Healthcare Companies To Watch In Right Now: Signature Bank (SBNY)
Signature Bank (the Bank) is a full-service commercial bank with 25 private client offices located in the New York metropolitan area serving the needs of privately owned business clients and their owners and senior managers. The Bank offers a variety of business and personal banking products and services through the Bank, as well as investment, brokerage, asset management and insurance products and services through its wholly owned subsidiary, Signature Securities Group Corporation (Signature Securities), a licensed broker-dealer and investment adviser. Through Signature Securities, it also purchases, securitizes and sells the guaranteed portions of the United States Small Business Administration (SBA) loans. The Bank offers a variety of deposit, escrow deposit, credit, cash management, investment and insurance products and services to its clients. As of December 31, 2011, the Bank maintained approximately 78,000 deposit accounts, 6,900 investment accounts, 8,600 loan accounts and 14,300 client relationships. In April 2012, it formed a new subsidiary, Signature Financial, LLC.
The Bank offers a range of products and services oriented to the needs of its business clients, including deposit products, such as non-interest-bearing checking accounts, money market accounts and time deposits; escrow deposit services; cash management services; commercial loans and lines of credit for working capital and to finance internal growth, acquisitions and leveraged buyouts; permanent real estate loans; letters of credit; investment products to help better manage idle cash balances, including money market mutual funds and short-term money market instruments; business retirement accounts, such as 401(k) plans, and business insurance products, including group health and group life products. It offers a range of products and services oriented to the needs of its high net worth personal clients, including interest-bearing and non-interest-bearing checking accounts, with optional features, such as debit/ autom! ated teller machine (ATM) cards and overdraft protection and, for its clients, rebates of certain charges, including ATM fees; money market accounts and money market mutual funds; time deposits; personal loans, both secured and unsecured; mortgages, home equity loans and credit card accounts; investment and asset management services, and personal insurance products, including health, life and disability.
Lending Activities
The Bank�� commercial and industrial (C&I) loan portfolio is consisted of lines of credit for working capital and term loans to finance equipment, company owned real estate and other business assets, along with commercial overdrafts. Its lines of credit for working capital are generally renewed on an annual basis and its term loans generally have terms of 2 to 5 years. The Bank�� lines of credit and term loans typically have floating interest rates, and as of December 31, 2011, approximately 61% of its outstanding C&I loans were variable rate loans. As of December 31, 2011, funded C&I loans totaled approximately 15% of its total funded loans. The Bank�� real estate loan portfolio includes loans secured by commercial and residential properties. It also provides temporary financing for commercial and residential property. As of December 31, 2011, funded real estate loans totaled approximately $5.74 billion, representing approximately 80% of its total funded loans. It issues standby or performance letters of credit, and can service the international needs of its clients through correspondent banks. As of December 31, 2011, its commitments under letters of credit totaled approximately $235.7 million. Its personal loan portfolio consists of personal lines of credit and loans to acquire personal assets. As of December 31, 2011, its consumer loans totaled $11.8 million, representing less than 1% of its total funded loans.
Investment and Asset Management Products and Services
Investment and asset management products and services are ! provided ! through the Bank�� subsidiary, Signature Securities. Signature Securities is a licensed broker-dealer. Signature Securities is an introducing firm and, as such, clears its trades through National Financial Services, Inc., a wholly owned subsidiary of Fidelity Investments. Signature Securities is also registered as an investment adviser in New York, New Jersey, Pennsylvania and Florida. It offers an array of asset management and investment products, including the ability to purchase and sell all types of individual securities, such as equities, options, fixed income securities, mutual funds and annuities. The Bank offers transactional, cash management type brokerage accounts with check writing and daily sweep capabilities. It also offers retirement products, such as individual retirement accounts (IRAs) and administrative services for retirement vehicles, such as pension, profit sharing, and 401(k) plans to its clients. Signature Securities offers wealth management services to its high net worth personal clients. Together with its client and their other professional advisors, including attorneys and certified public accountants, it develops a financial plan that can include estate planning, business succession planning, asset protection, investment management, family office advisory services, bill payment, art and collectible advisory services and concentrated stock services.
Sources of Funds
The Bank offers a variety of deposit products to its clients. Its business deposit products include commercial checking accounts, money market accounts, escrow deposit accounts, lockbox accounts, cash concentration accounts and other cash management products. Its personal deposit products include checking accounts, money market accounts and certificates of deposit. The Bank also allows its personal and business deposit clients to access their accounts, transfer funds, pay bills and perform other account functions over the Internet and through ATM machines. As of December 31, 2011, it main! tained ap! proximately 78,000 deposit accounts representing $11.70 billion in client deposits, excluding brokered deposits.
Insurance Services
The Bank offers its business and private clients an array of individual and group insurance products, including health, life, disability and long-term care insurance products through its subsidiary, Signature Securities. The Bank does not underwrite insurance policies. It only acts as an agent in offering insurance products and services underwritten by insurers.
Advisors' Opinion:- [By Ben Levisohn]
Each month, Credit Suisse’s small-cap strategists ask the firm’s analyst to name their favorite small- and mid-cap stocks. This month, six new stocks made the list: RPM International (RPM), SunCoke Energy (SXC), Zions Bancorp (ZION), Signature Bank (SBNY), Edwards Lifesciences (EW) and�Rexnord (RXN).
Top 10 Managed Healthcare Companies To Watch In Right Now: Prometheus RxDx Corp (RXDX)
Prometheus RxDx Corp., incorporated in June 2009, is a wholly owned subsidiary of Prometheus Laboratories Inc. The Company is engaged in the development and commercialization of pharmaceutical and diagnostic products that enable physicians to provide individualized patient care. It focuses on the detection, diagnosis and treatment of disorders within the fields of gastroenterology and oncology. It operates in two segments: the pharmaceutical products segment that markets and sells prescription drugs, and the diagnostic testing services segment, which includes specific immunoassays to detect and differentiate diseases, pharmacogenetic testing and drug metabolite monitoring. The pharmaceutical products for gastrointestinal diseases and disorders includes ENTOCORT EC (budesonide) Capsules, which is indicated for the treatment of mild to moderate active Crohn�� disease involving the ileum and/or the ascending colon, and LOTRONEX (alosetron hydrochloride) Tablets, for use in female patients with severe diarrhea-predominant irritable bowel syndrome (IBS).
Gastroenterology Pharmaceutical Products
The pharmaceutical products for gastrointestinal diseases and disorders include Entocort EC for the treatment of mild to moderate active Crohn�� disease involving the ileum and/or ascending colon and Lotronex for treatment of a subset of women with severe diarrhea-predominant IBS. The Company sells but does not market, several other pharmaceuticals, including Imuran, Helidac Therapy, and Ridaura, in addition to a number of other diagnostic tests. It also manufactures a generic mercaptopurine product, which is sold through a third-party distributor. It only offers pharmaceutical products in the United States. It began selling Proleukin in February 2010 under an exclusive distribution and promotion agreement with Novartis. Proleukin is a recombinant human interleukin-2 for treatment in adults with metastatic renal cell carcinoma and metastatic melanoma. Proleukin therapy is a form of im! munotherapy that uses the body�� natural immune system to fight cancer. In December 2010, it signed an agreement with ThePharmaNetwork, LLC, to sell Trandate and Zyloprim.
Entocort EC is the Food and Drug Association- approved drug indicated for the induction and maintenance of clinical remission in mild to moderate active Crohn�� disease involving the ileum and/or the ascending colon. Entocort EC consists of an encapsulated formulation of budesonide granules, a glucocorticosteroid. Entocort EC is designed to release primarily in the ileum and/or the ascending colon, so that as little as 10% of the drug enters systemic circulation. Entocort EC may benefit patients by reducing glucocorticosteroid-related side effects. Lotronex is indicated for use only in women with severe diarrhea-predominant IBS who have not responded adequately to conventional therapy, whose IBS symptoms are chronic, and who have had other gastrointestinal medical conditions ruled out.
Imuran is indicated for adjunctive use in the prevention of rejection in kidney transplants and in the management of active rheumatoid arthritis. Although Imuran is not indicated for the treatment of IBD and the Company does not promote it for that indication, physicians often prescribe it for various forms of IBD, including Crohn�� disease and ulcerative colitis, as well as other autoimmune disorders. Imuran is prescribed primarily by gastroenterologists, transplant surgeons, nephrologists, rheumatologists and internal medicine specialists. Helidac Therapy (Hediac), when taken with a hydrogen (H2 ) antagonist, is indicated for the eradication of Helicobacter pylori, or H. pylori, bacteria, which causes peptic ulcers, and for patients with duodenal ulcer disease. Ridaura is approved for the treatment of active classical or definite rheumatoid arthritis in adults. Ridaura is the oral formulation of a gold salt available for the treatment of rheumatoid arthritis for patients who have not responded adequately to one or mor! e non-ste! roidal anti-inflammatory drugs. Mercaptopurine is approved for maintenance for acute lymphatic leukemia as part of a combination regimen and, although it is not indicated for the treatment of certain gastrointestinal diseases and it does not promote it for those indications, physicians often prescribe it for various forms of IBD, including Crohn�� disease and ulcerative colitis.
Trandate is approved for the management of high blood pressure, or hypertension. Trandate can be used alone or in combination with other anti-hypertensive agents, particularly thiazide and loop diuretics. Trandate is typically prescribed by cardiologists, family practitioners and internists. Trandate competes both with generics and many other drugs used to treat hypertension. In December 2010, the Company signed an agreement with ThePharmaNetwork, LLC, to sell Trandate. Zyloprim reduces serum and uric acid levels and is approved for the management of patients with gout, patients receiving certain types of chemotherapy to leukemia, lymphoma and other cancers, and patients with kidney or urinary stones. Zyloprim is prescribed by orthopedic specialists, rheumatologists, podiatrists, nephrologists and family practitioners.
Gastroenterology Diagnostic Testing Services
The diagnostic testing services are designed to aid physicians in making diagnoses with non-invasive testing and to assist them in determining therapy treatment and management, thereby helping a physician customize treatment to an individual patient. The Company performs all its diagnostic testing services in its laboratory located in San Diego, California. During the year ended December 31, 2010, it launched PROMETHEUS Crohn�� Prognostic, the serogenetic prognostic test for Crohn�� disease. The Company offers three celiac tests to physicians, including antibody tests, a genetics test and a panel that combines both the antibody and genetics tests.
The Company competes with Quest Diagnostics Incorporated and La! boratory ! Corporation of America Holdings
Advisors' Opinion:- [By James E. Brumley]
Quick - what do CytRx Corporation (NASDAQ:CYTR) and Ignyta Inc. (NASDAQ:RXDX) have in common? Yes, they're both biotech stocks, but that's not the absolute best answer right now. The most meaningful common element between RXDX and CYTR right now is, each is on the verge of a big technical breakout and deserves a spot on your watchlist. Here's a closer look at each.�
Top 10 Managed Healthcare Companies To Watch In Right Now: Virgin Media Inc.(VMED)
Virgin Media Inc., through its subsidiaries, provides entertainment and communications services in the United Kingdom. The company offers cable broadband Internet, television, and fixed line telephone services under the Virgin Media brand to residential customers; mobile telephony services through Virgin Mobile, a mobile virtual network operator; broadband and telephone services to residential customers through third-party telecommunications networks; and video on demand services, including access to movies, television programs, music videos, and other on-demand content, as well as provides digital video recorders. It also offers voice, data, and Internet solutions to commercial customers comprising analog telephony and managed data networks and applications, as well as supplies communications services to health and emergency services providers. As of December 31, 2011, the company provided cable broadband services to approximately 4 million subscribers; cable television s ervices to approximately 3.76 million residential subscribers; cable telephony services to approximately 4.2 million residential subscribers; mobile telephony services to approximately 3 million customers; non-cable fixed line telephone services to approximately 163,300 subscribers; and voice, data, and Internet solutions to approximately 50,000 businesses and 250 public sector organizations. The company offers its products and services through telesales, customer care centers, and online, as well as through its sales force. It serves mobile and fixed-line service providers, systems integrators, and Internet service providers; and private and public sector organizations. The company was formerly known as NTL Incorporated and changed its name to Virgin Media Inc. in February 2007. The company was founded in 1993 and is based in New York, New York.
Advisors' Opinion:- [By Tim Brugger]
Upon Liberty Global's (NASDAQ: LBTYA ) successfully closing its acquisition of Virgin Media (NASDAQ: VMED ) , Tom Mockridge will assume CEO responsibilities of the U.K. communications firm, Liberty Global announced today.
- [By Markos Kaminis]
Whether the stock is overvalued or not does not matter at this point, because an impact to its subscriber base due to the data sharing news would probably change market expectations for the company's operations and affect both earnings estimates and valuation multiples. It would probably drive the shares lower in my view, and I see no reason to risk that by holding the stock. Long-term holders, of course, have tax considerations to consider, and the news is still filing out. If Verizon's peers are also implicated clearly, perhaps with the aid of a Verizon PR push, this issue would be effectively mitigated. Though even in that case, there could be market share loss by all major American firms, with companies like T-Mobile US (TMUS) and Virgin Media (VMED) benefiting, whether they have also been involved or not. In any event, for new stakeholders, or those willing to deal with tax implications; or for those interested in a potential short opportunity, I would sell the stock today. I see no reason to bear risk while this issue and its implications are still unraveling, and while VZ has thus far not been significantly discounted for it.
Top 10 Managed Healthcare Companies To Watch In Right Now: Brunswick Corp (BC)
Brunswick Corporation (Brunswick), incorporated on December 31, 1907, is a worldwide designer, manufacturer and marketer of recreation products, including marine engines, boats, fitness equipment and bowling and billiards equipment. Brunswick�� engine products include outboard, sterndrive and inboard engines; trolling motors; propellers; engine control systems, and marine parts and accessories. The Company�� boat offerings include fiberglass boats; sportfishing convertibles and motoryachts; offshore fishing boats; aluminum fishing boats, and pontoon and deck boats. Brunswick�� fitness products include both cardiovascular and strength training equipment for the commercial and consumer markets. Brunswick�� bowling products include capital equipment, aftermarket and consumer goods. The Company also sells a range of billiards tables and other gaming tables and accessories. In addition, the Company owns and operates Brunswick bowling family entertainment centers in the United States and other countries. In August 2013, Brunswick Corporation completed the sale of the Hatteras and CABO brands of motoryachts and sportfishing convertibles to Navis HCY Acquisition.
The Company, through its Brunswick Financial Services Corporation (BFS) subsidiary, owns a 49% interest in a joint venture, Brunswick Acceptance Company, LLC (BAC). CDF Ventures, LLC (CDFV), a subsidiary of GE Capital Corporation, owns the remaining 51%. Under the terms of the joint venture agreement, BAC provides secured wholesale inventory floorplan financing to the Company�� engine and boat dealers.
Marine Engine Segment
Mercury Marine manufactures and markets a range of sterndrive propulsion systems, inboard engines and outboard engines under the Mercury, Mercury MerCruiser, Mariner, Mercury Racing, Mercury SportJet and Mercury Jet Drive, MotorGuide, Axius and Zeus brand names. In addition, Mercury Marine manufactures and markets marine parts and accessories under the Quicksilver, Mercury Precision! Parts, Mercury Propellers, Attwood, Land ����Sea, Kellogg Marine Supply, Diversified Marine Products, Sea Choice and MotorGuide brand names, including marine electronics and control integration systems, steering systems, instruments, controls, propellers, trolling motors, service parts and marine lubricants. Mercury Marine�� sterndrive engines, inboard engines and outboard engines are sold to independent boat builders, local, state and foreign governments, and to the Company�� Boat segment. In addition, Mercury Marine�� outboard engines are sold to end-users through a global network of more than 7,000 marine dealers and distributors, specialty marine retailers and marine service centers.
Mercury Marine, through Cummins MerCruiser Diesel Marine LLC (CMD), a joint venture between Brunswick�� Mercury Marine division and Cummins Marine, a division of Cummins Inc., supplies integrated diesel propulsion systems to the worldwide recreational and commercial marine markets, including the Company�� Boat segment. Mercury Marine manufactures two-stroke OptiMax outboard engines ranging from 75 to 300 horsepower, all of which feature Mercury�� direct fuel injection (DFI) technology, and four-stroke outboard engine include Verado, a collection of supercharged outboards ranging from 150 to 350 horsepower, and Mercury Marine's naturally aspirated four-stroke outboards, ranging from 2.5 to 150 horsepower including the introduction of the 150 FourStroke, which is quickly becoming known for its light weight, fuel efficiency and performance. In addition, most of Mercury�� sterndrive and inboard engines are available with catalyst exhaust monitoring and treatment systems.
Mercury Marine�� sterndrive and outboard engines are produced domestically in Fond du Lac, Wisconsin, with outboard engines also produced internationally in China and Japan. Mercury Marine manufactures 40, 50 and 60 horsepower four-stroke outboard engines in a facility in China, and produces smaller outboard en! gines in ! Japan pursuant to a joint venture with its partner, Tohatsu Corporation. CMD manufactures diesel marine propulsion systems in South Carolina.
Mercury Marine also operates a remanufacturing business for engines and service parts in Wisconsin. In addition, Mercury Marine has an equity ownership interest in a company that manufactures boats under the brand names Bella, Flipper and Aquador in Finland. Mercury Marine also has an interest in a company that manufactures boats under the brand names Bella, Flipper and Aquador in Finland. Mercury Marine�� parts and accessories distribution businesses include Land ����Sea, Kellogg Marine Supply and Diversified Marine Products. These businesses are the distributors of marine parts and accessories throughout North America.
Boat Segment
The Boat Group consists of the boat brands, such Sea Ray yachts, sport yachts, sport cruisers and runabouts; Bayliner sport cruisers and runabouts; Meridian motoryachts; Boston Whaler, Lund and Trophy fiberglass fishing boats, and Crestliner, Cypress Cay, Harris FloteBote, Lowe, Lund, Princecraft, Suncruiser and Triton aluminum fishing, utility, pontoon and deck boats. The Boat Group also includes a commercial and governmental sales unit that sells products to commercial customers, as well as the United States Government and state, local and foreign governments. The Boat Group procures most of its outboard engines, gasoline sterndrive engines and gasoline inboard engines from Brunswick�� Marine Engine segment.
The Boat Group has active manufacturing facilities in Florida, Indiana, Minnesota, Missouri, North Carolina, Tennessee, Canada, Mexico and Portugal, as well as additional inactive manufacturing facilities in Florida, Maryland, North Carolina and Tennessee. The Boat Group utilizes contract manufacturing facilities in Argentina and Poland. The Boat Group has constructed a manufacturing plant in Joinville, Santa Catarina, Brazil, which has nearly 150,000 square feet of man! ufacturin! g space. The Boat Group�� products are sold to end-users through a worldwide network of approximately 2,850 dealers and distributors, each of which carries one or more of Brunswick�� boat brands.
Fitness Segment
Brunswick�� Fitness segment consists of its Life Fitness division (Life Fitness), which designs, manufactures and markets a range of cardiovascular fitness equipment (including treadmills, total body cross-trainers, stair climbers and stationary exercise bicycles) and strength-training equipment under the Life Fitness and Hammer Strength brands. Life Fitness��commercial sales customers include health clubs, fitness facilities operated by professional sports teams, the military, governmental agencies, corporations, hotels, schools and universities. Consumer products are available at specialty retailers, select mass merchants, sporting goods stores, through international distributors, and on Life Fitness��Website. The Fitness segment�� principal manufacturing facilities are located in Illinois, Kentucky, Minnesota and Hungary. Life Fitness distributes its products worldwide from regional warehouses and production facilities.
Bowling & Billiards Segment
The Bowling & Billiards segment consists of the Brunswick Bowling & Billiards division (BB&B). BB&B is a worldwide designer, manufacturer and marketer of bowling products. BB&B's bowling products business designs, manufactures and markets a variety of bowling products, including capital equipment (such as automatic pinsetters and scoring devices), bowling balls and aftermarket products (such as lane machines, pinsetter parts, lane conditioners and lane cleaners). Through licensing arrangements, BB&B also offers an array of bowling consumer products, including bowling shoes, bags and accessories.
BB&B operates 95 bowling centers in the United States, Canada and Europe. BB&B retail bowling centers offer bowling and, depending on size and location, may also offer activities a! nd facili! ties: restaurants, lounges, snack bars, billiards, video and redemption games, laser tag, pro shops and meeting and party rooms. Of the Company's 95 bowling centers, 42 have been converted into Brunswick Zones, which are bowling centers that offer an array of active entertainment activities for its guests. BB&B designs and/or markets billiards tables, table tennis tables, air powered table hockey games, billiard balls, cues and other gaming tables, as well as game room furniture and related accessories, under the Brunswick and Contender brands. BB&B's primary manufacturing and distribution facilities are located in Michigan, Wisconsin, Hungary and Mexico. Brunswick�� bowling and billiards products are sold through a variety of channels, including distributors, dealers, mass merchandisers, bowling centers and retailers, and directly to consumers on the Internet and through other outlets.
Advisors' Opinion:- [By Jeremy Bowman]
What: Shares of Brunswick (NYSE: BC ) were getting fired up today, climbing as much as 12% after issuing a strong quarterly report and improved guidance. �
- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Brunswick (NYSE: BC ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Brunswick doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 3.0%, and inventory increased 8.4%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue increased 3.7%, and inventory increased 8.4%. Over the sequential quarterly period, the trend looks healthy. Revenue grew 19.9%, and inventory grew 5.0%.
No comments:
Post a Comment